Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05488847 · ClinicalTrials.gov registry record · Phase 4

Opioid-Free Pain Protocol After Shoulder Arthroplasty

A Phase 4 study of Shoulder Pain and Shoulder Arthropathy, sponsored by Henry Ford Health System.

Active
Registry status
Phase 4
Development phase
83
Enrollment target
1
Study location

NCT05488847 is a Phase 4 study of Shoulder Pain and Shoulder Arthropathy that is active but no longer recruiting, run by Henry Ford Health System. The registered enrollment target is 83 participants, below the 98-participant average among 27 other Shoulder Pain trials with a reported enrollment target (15% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05488847, a Phase 4 study of Shoulder Pain and Shoulder Arthropathy, is active but no longer recruiting, sponsored by Henry Ford Health System.

ACTIVE NOT RECRUITING
Registry status
Phase 4
Development phase
83 participants
Enrollment target
1
Study location

Study Summary

This randomized, single blinded, clinical trial aims to investigate the efficacy of a multimodal pain control regimen for shoulder arthroplasty. Patients who receive a multimodal pain control regimen alone (study group) will be compared to patients who receive a multimodal pain control regimen plus a standard prescription of an opioid containing medication (comparison group). The primary outcome is average daily Numerical Rating Scale (NRS) pain score in the first 10 days after surgery. We hypothesize that there will be no significant difference in the primary outcome between the two groups.

Conditions Studied

Shoulder Pain Shoulder Arthropathy

Interventions

  • DRUG Acetaminophen
  • DRUG Dexamethasone
  • DRUG Celecoxib
  • DRUG Tramadol
  • DRUG Pregabalin

Study Locations (1)

Michigan

  • Henry Ford Health - Detroit

Trial Details

FieldValue
Enrollment Target 83 participants
Start Date 2022-06-25
Est. Completion 2026-09-01
Phase Phase 4

Sponsor

Henry Ford Health System

234 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT05488847

The ClinicalTrials.gov registry entry for NCT05488847 describes a study currently listed as active not recruiting, categorized as Phase 4. The registered enrollment target is 83 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 98-participant average among 27 other Shoulder Pain trials with a reported enrollment target (15% lower). The listed sponsor is Henry Ford Health System, which has 234 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Shoulder Pain appearing as the primary indexed condition, and to 5 interventions - of which Acetaminophen is the first listed.

NCT05488847 reports 1 study location spanning 1 distinct geographic area - top geographies include Michigan.

Frequently Asked Questions

What is clinical trial NCT05488847 about?

NCT05488847 is a clinical study titled "Opioid-Free Pain Protocol After Shoulder Arthroplasty". This randomized, single blinded, clinical trial aims to investigate the efficacy of a multimodal pain control regimen for shoulder arthroplasty. Patients who receive a multimodal pain control regimen alone (study group) will be compared to patients who receive a multimodal pain control regimen plus ...

What is the current status of trial NCT05488847?

This trial is currently active not recruiting. It is a Phase 4 study. The enrollment target is 83 participants. The study started on 2022-06-25. Estimated completion is 2026-09-01.

What conditions does trial NCT05488847 study?

This clinical trial studies the following conditions: Shoulder Pain, Shoulder Arthropathy.

What interventions are being tested in trial NCT05488847?

The interventions under investigation include: Acetaminophen (DRUG), Dexamethasone (DRUG), Celecoxib (DRUG), Tramadol (DRUG), Pregabalin (DRUG).

Who is sponsoring clinical trial NCT05488847?

This trial is sponsored by Henry Ford Health System, which has 234 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05488847 being conducted?

This trial has 1 study location across Michigan. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Shoulder Pain

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Shoulder Pain

All registered trials for this condition

Shoulder Arthropathy

All registered trials for this condition

Michigan

All trials with a study site in Michigan

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.